2. Academic Validation
  3. Indolylmaleimide Derivative IM-17 Shows Cardioprotective Effects in Ischemia-Reperfusion Injury

Indolylmaleimide Derivative IM-17 Shows Cardioprotective Effects in Ischemia-Reperfusion Injury

  • ACS Med Chem Lett. 2018 Jan 29;9(3):182-187. doi: 10.1021/acsmedchemlett.7b00454.
Kosuke Dodo 1 2 3 4,  Tadashi Shimizu 1 3,  Jun Sasamori 5,  Kazuyuki Aihara 5,  Naoki Terayama 1 4,  Shuhei Nakao 1 4,  Katsuya Iuchi 1 2,  Masahiro Takahashi 3,  Mikiko Sodeoka 1 2 4
Affiliations

Affiliations

  • 1 RIKEN, Synthetic Organic Chemistry Laboratory, 2-1, Hirosawa, Wako-shi, Saitama 351-0198, Japan.
  • 2 Sodeoka Live Cell Chemistry Project, ERATO, JST, 2-1, Hirosawa, Wako-shi, Saitama 351-0198, Japan.
  • 3 Institute of Multidisciplinary Research for Advanced Materials (IMRAM), Tohoku University, 2-1-1, Katahira, Aoba, Sendai, Miyagi 980-8577, Japan.
  • 4 AMED-CREST, AMED, 2-1 Hirosawa, Wako-shi, Saitama 351-0198, Japan.
  • 5 Drug Research Department, Fukushima Research Laboratories, Toa Eiyo Ltd., 1,Yuno-tanaka, Iizaka-machi, Fukushima-shi, Fukushima 960-0280, Japan.
PMID: 29541357 DOI: 10.1021/acsmedchemlett.7b00454
Abstract

We previously developed IM-54 as a novel type of inhibitor of hydrogen-peroxide-induced necrotic cell death. Here, we examined its cell death inhibition profile. IM-54 was found to selectively inhibit oxidative stress-induced necrosis, but it did not inhibit Apoptosis induced by various Anticancer drugs or Fas ligand, or Necroptosis. IM-17, an IM derivative having improved water-solubility and metabolic stability, was developed and confirmed to retain necrosis-inhibitory activity. IM-17 showed cardioprotective effects in an isolated rat heart model and an in vivo arrhythmia model, suggesting that IM derivatives may have therapeutic potential.

Figures
Products
嗨！很高兴为您提供帮助！

尊敬的 MCE 客户您好，
请您选择所在区域，我们将转接对应客服为您服务！

热门区域

A

B

C

F

G

H

J

L

N

Q

S

T

X

Y

Z

热 A B C F G H J L N Q S T X Y Z